Simmons EC, Scholpa NE, Schnellmann RG. FDA-approved 5-HT1F receptor agonist lasmiditan induces mitochondrial biogenesis and enhances locomotor and blood-spinal cord barrier recovery after spinal cord injury. Exp Neurol 2021 Apr 10:113720. doi: 10.1016/j.expneurol.2021.113720.
PMID: 33848513